Beyond Dashboards: The Rise of Decision Intelligence in Pharma
This story is from 2026-09-03. It is preserved in the archive; the latest stories are on the live feed.
When Dashboards Stop Being Enough For years, pharmaceutical companies invested heavily in dashboards. They tracked clinical enrollment, manufacturing performance, R&D spending, commercial KPIs, supply levels, and patient metrics. Business Intelligence transformed large volumes of information into c…
Read the full story at DEV Community — AI ↗
Timeline · 1 report
- 2026-09-03 07:01 · DEV Community — AI
Beyond Dashboards: The Rise of Decision Intelligence in Pharma